It’s that time of year when we reflect on the progress we made over the past 12 months – and in the world of cancer research, that progress has been monumental. From approval of the first cancer immunotherapy for lung cancer, to research showing less is more when it comes to treatment for early-stage breast cancer, to the launch of the innovative, international data sharing project AACR Project Genie, to a campaign that led to an historic increase in funding for the National Institutes of Health, the American Association for Cancer Research’s blog, Cancer Research Catalyst, has chronicled it all.
We started the year off with a post from three experts who forecasted what cancer prevention and therapies would look like in 2015, and we’re pleased to note those predictions were spot on. It was our most popular post of 2015. Listed below are the top ten most read posts of the year. Thanks for reading Cancer Research Catalyst, and Happy New Year!
- Experts Forecast Cancer Prevention and Therapies in 2015
- FDA Approves First Immunotherapy for Children With Cancer
- Cancer Causes: Inheritance, ‘Bad Luck,’ and the Environment
- Advances in Immunotherapy: Fine-tuning CAR T Cells
- FDA Approves First Immunotherapy-Companion Diagnostic Combo for Lung Cancer
- Personalizing Targeted Immunotherapy: The Promise and the Problem
- Advancing Immunotherapy for Lung Cancer
- SABCS 2014: Immunotherapy Shows Early Promise for Triple-negative Breast Cancer Patients
- New Immunotherapy Advances Presented at the AACR Annual Meeting 2015
- The Immune System and Cancer
You may also like: